DrugPatentWatch Database Preview
Arbor Pharms Llc Company Profile
What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has twenty-two approved drugs.
There are nineteen US patents protecting ARBOR PHARMS LLC drugs.
Summary for Arbor Pharms Llc
| US Patents: | 19 |
| Tradenames: | 23 |
| Ingredients: | 15 |
| NDAs: | 22 |
Drugs and US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-004 | Oct 25, 2011 | AA | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Arbor Pharms Llc | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-002 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Arbor Pharms Llc | ERYTHROCIN STEARATE | erythromycin stearate | TABLET;ORAL | 060359-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-002 | Dec 20, 2011 | 5,736,555 | ➤ Try a Free Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 4,757,128 | ➤ Try a Free Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | 5,958,961 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2008518971 | ➤ Try a Free Trial |
| European Patent Office | 1569895 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 200970896 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 12/008 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209 |
| 6 | Finland | ➤ Try a Free Trial | |
| 962 | Luxembourg | ➤ Try a Free Trial | 91962, EXPIRES: 20261207 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
